Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 4:10:880155.
doi: 10.3389/fbioe.2022.880155. eCollection 2022.

Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells

Affiliations
Review

Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells

Zheng-Mei Li et al. Front Bioeng Biotechnol. .

Abstract

Recombinant therapeutic proteins (RTPs) are important parts of biopharmaceuticals. Chinese hamster ovary cells (CHO) have become the main cell hosts for the production of most RTPs approved for marketing because of their high-density suspension growth characteristics, and similar human post-translational modification patterns et al. In recent years, many studies have been performed on CHO cell expression systems, and the yields and quality of recombinant protein expression have been greatly improved. However, the expression levels of some proteins are still low or even difficult-to express in CHO cells. It is urgent further to increase the yields and to express successfully the "difficult-to express" protein in CHO cells. The process of recombinant protein expression of is a complex, involving multiple steps such as transcription, translation, folding processing and secretion. In addition, the inherent characteristics of molecular will also affect the production of protein. Here, we reviewed the factors affecting the expression of recombinant protein and improvement strategies in CHO cells.

Keywords: CHO; difficult to express; expression vector; recombinant protein; recombinant therapeutic proteins.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Process of protein synthesis. mRNA is transcribed in the nucleus, transported to the cytoplasm and translated by the ribosome, and then the protein binds to the rough endoplasmic reticulum, folding and processing before entering the Golgi apparatus. The soluble protein is PTMs and then secreted through the secretory pathway. Through cell engineering strategies such as anti-apoptotic engineering, metabolic engineering, cell cycle engineering, and protein PTMs engineering, overexpression of dominant genes, gene knockout, and siRNA interference inhibit unfavorable gene expression, transform mammalian cell lines, and improve cell lines Performance, effectively improve cell viability and increase the production of recombinant protein.

Similar articles

Cited by

References

    1. Alves C. S., Dobrowsky T. M. (2017). Strategies and Considerations for Improving Expression of "Difficult to Express" Proteins in CHO Cells. Methods Mol. Biol. 1603, 1–23. 10.1007/978-1-4939-6972-2_1 - DOI - PubMed
    1. Amadi I. M., Agrawal V., Christianson T., Bardliving C., Shamlou P., LeBowitz J. H. (2020). Inhibition of Endogenous Mir-23a/Mir-377 in CHO Cells Enhances Difficult-to-Express Recombinant Lysosomal Sulfatase Activity. Biotechnol. Prog. 36 (3), e2974. 10.1002/btpr.2974 - DOI - PubMed
    1. Ang K. S., Kyriakopoulos S., Li W., Lee D. Y. (2016). Multi-Omics Data Driven Analysis Establishes Reference Codon Biases for Synthetic Gene Design in Microbial and Mammalian Cells. Methods 102, 26–35. 10.1016/j.ymeth.2016.01.016 - DOI - PubMed
    1. Astley K., Al-Rubeai M. (2008). The Role of Bcl-2 and its Combined Effect with p21CIP1 in Adaptation of CHO Cells to Suspension and Protein-free Culture. Appl. Microbiol. Biotechnol. 78, 391–399. 10.1007/s00253-007-1320-2 - DOI - PubMed
    1. Baek E., Noh S. M., Lee G. M. (2017). Anti-Apoptosis Engineering for Improved Protein Production from CHO Cells. Methods Mol. Biol. 1603, 71–85. 10.1007/978-1-4939-6972-2_5 - DOI - PubMed

LinkOut - more resources